|
Volumn 19, Issue 3, 2000, Pages 177-
|
Prepulsid withdrawn from UK and US markets
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISAPRIDE;
CARDIOVASCULAR DISEASE;
DRUG CONTROL;
DRUG FATALITY;
DRUG SAFETY;
EDITORIAL;
HEART ARRHYTHMIA;
HEART VENTRICLE FIBRILLATION;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
RISK BENEFIT ANALYSIS;
STOMACH PARESIS;
TREATMENT FAILURE;
UNITED KINGDOM;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ARRHYTHMIA;
CHILD, PRESCHOOL;
CISAPRIDE;
DRUG AND NARCOTIC CONTROL;
EUROPEAN UNION;
GASTROINTESTINAL AGENTS;
GREAT BRITAIN;
HUMAN;
INFANT;
INFANT, NEWBORN;
UNITED STATES;
VENTRICULAR DYSFUNCTION;
|
EID: 0033782151
PISSN: 0964198X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (12)
|
References (0)
|